CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 163 filers reported holding CLOVIS ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $64,000 | -63.2% | 53,447 | -16.7% | 0.01% | -66.7% |
| Q4 2021 | $174,000 | -63.1% | 64,126 | -39.3% | 0.02% | -56.1% |
| Q3 2021 | $471,000 | -52.8% | 105,562 | -38.6% | 0.04% | -57.7% |
| Q2 2021 | $998,000 | +101.2% | 171,994 | +102.2% | 0.10% | +14.1% |
| Q3 2020 | $496,000 | +93.8% | 85,075 | +246.2% | 0.08% | +240.0% |
| Q4 2019 | $256,000 | +19.1% | 24,572 | +183.4% | 0.02% | +108.3% |
| Q1 2019 | $215,000 | -68.2% | 8,669 | +5.6% | 0.01% | -63.6% |
| Q3 2017 | $676,000 | – | 8,209 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |